GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » UCB SA (XBRU:UCB) » Definitions » Days Inventory

UCB (XBRU:UCB) Days Inventory

: 195.91 (As of Dec. 2023)
View and export this data going back to 1988. Start your Free Trial

Days Inventory is also known as Days Sales of Inventory (DSI). UCB's Average Total Inventories for the six months ended in Dec. 2023 was €972 Mil. UCB's Cost of Goods Sold for the six months ended in Dec. 2023 was €905 Mil. Hence, UCB's Days Inventory for the six months ended in Dec. 2023 was 195.91.

The historical rank and industry rank for UCB's Days Inventory or its related term are showing as below:

XBRU:UCB' s Days Inventory Range Over the Past 10 Years
Min: 173.69   Med: 198.98   Max: 219.81
Current: 203.13

During the past 13 years, UCB's highest Days Inventory was 219.81. The lowest was 173.69. And the median was 198.98.

XBRU:UCB's Days Inventory is ranked worse than
52.85% of 649 companies
in the Biotechnology industry
Industry Median: 190.88 vs XBRU:UCB: 203.13

UCB's Days Inventory increased from Dec. 2022 (194.37) to Dec. 2023 (195.91). It might indicate that UCB's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. UCB's Inventory Turnover for the six months ended in Dec. 2023 was 0.93.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. UCB's Inventory-to-Revenue for the six months ended in Dec. 2023 was 0.36.


UCB Days Inventory Historical Data

The historical data trend for UCB's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

UCB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Inventory
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 205.38 218.79 219.81 194.49 207.20

UCB Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Inventory Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 215.88 187.79 194.37 206.96 195.91

Competitive Comparison

For the Biotechnology subindustry, UCB's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


UCB Days Inventory Distribution

For the Biotechnology industry and Healthcare sector, UCB's Days Inventory distribution charts can be found below:

* The bar in red indicates where UCB's Days Inventory falls into.



UCB Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

UCB's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

Days Inventory (A: Dec. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2022 ) + Total Inventories (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (907 + 1031) / 2 ) / 1707*365
=969 / 1707*365
=207.20

UCB's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

Days Inventory (Q: Dec. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Jun. 2023 ) + Total Inventories (Q: Dec. 2023 )) / count ) / Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=( (912 + 1031) / 2 ) / 905*365 / 2
=971.5 / 905*365 / 2
=195.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


UCB  (XBRU:UCB) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

UCB's Inventory Turnover for the six months ended in Dec. 2023 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

UCB's Inventory to Revenue for the six months ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


UCB Days Inventory Related Terms

Thank you for viewing the detailed overview of UCB's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


UCB (XBRU:UCB) Business Description

Address
Allee de la Recherche, 60, Brussels, BEL, B-1070
UCB is a Belgium-based biopharma firm focused on the development of novel therapies for the treatment of central nervous system and immunologic diseases. Historically, revenue was derived from allergy medicine Zyrtec and epilepsy drug Keppra, which have both lost patent protection. The firm's key products are Cimzia (immunology), Vimpat (epilepsy), Neupro (Parkinson's disease and restless leg syndrome), Briviact (epilepsy), Bimzelx (psoriasis), Evenity (osteoporosis), Nayzilam (cluster seizures), and Fintepla (Dravet Syndrome and Lennox-Gastaut Syndrome).

UCB (XBRU:UCB) Headlines

No Headlines